3 Results for "

sPLA2s

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "sPLA2s" in MCE Product Catalog:

Cat. No.: HY-145384
CAS No.: 1048660-43-0
Pureté:  99.48%
Target:  

Phospholipase

Domaines de recherche:  

Inflammation/Immunology

ROC-0929 (compound 13a) is a potent and selective inhibitor of secreted phospholipases A2 (sPLA2s) with an IC50 of 80 nM, specially targeting hGX. ROC-0929 inhibits the phosphorylation of ERK1/2 and p-38. Secreted phospholipases A2 (sPLA2s) are a family of disulfide-rich, Ca 2+-dependent enzymes that hydrolyze the sn-2 position of glycero-phospholipids to release a fatty acid and a lysophospholipid. ROC-0929 has the potential for researching inflammation related diseases .
loading...
    loading...
Cat. No.: HY-120078
CAS No.: 1845753-81-2
Target:  

Phospholipase

Domaines de recherche:  

Cardiovascular Disease

AZD2716 is an orally active secretory phospholipase A2 (sPLA2) inhibitor. AZD2716 inhibits human GIIA sPLA2 (IC50=10 nM), human GV sPLA2 (IC50=40 nM), human GX sPLA2 (IC50=400 nM), snake venom sPLA2 (IC50=2 pM), and snake (Bothrops jararacussu) Lys49-PLA2-like toxin (Kd=110 μM). AZD2716 inhibits sPLA2 isoforms IIa, V, X, snake venom sPLA2s, and snake venom Lys49-PLA2-like toxin myotoxic activity via hydrophobic channel binding. AZD2716 suppresses GIIA sPLA2 production, neutralizes snake venom-induced myotoxicity, and improves survival in envenomed mice. AZD2716 can be used for the research of coronary artery disease, atherosclerosis, and snakebite envenoming [2] .
loading...
    loading...
Cat. No.: HY-RS10622
Domaines de recherche:  

Others

PLA2G2D Human Pre-designed siRNA Set A contains three designed siRNAs for PLA2G2D gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...